Variable expression of activation-linked surface antigens on human mast cells in health and disease

被引:75
作者
Valent, F
Schernthaner, GH
Sperr, WR
Fritsch, G
Agis, H
Willheim, M
Bühring, HJ
Orfao, A
Escribano, L
机构
[1] Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, A-1090 Vienna, Austria
[2] St Anna Childrens Hosp, A-1090 Vienna, Austria
[3] Univ Vienna, Inst Pathophysiol, Vienna, Austria
[4] Univ Tubingen, Dept Internal Med 2, Tubingen, Germany
[5] Univ Salamanca, Ctr Invest Canc, Serv Cent Citometria, Madrid, Spain
[6] Univ Alcala de Henares, Hosp Ramon y Cajal, Mast Cell Unit, Serv Hematol, Madrid, Spain
关键词
D O I
10.1034/j.1600-065X.2001.790108.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mast cells (MC) are multipotent effector cells of the immune system. They contain an array of biologically active mediator substances in their granules. MC also express a number of functionally important cell surface antigens, including stem cell factor receptor (SCFR=kit=CD117), high affinity IgER (Fc epsilon RI), or C5aR (CD88). Respective ligands can induce or promote degranulation, migration, or cytokine production. Other integral surface molecules can mediate adhesion or cell aggregation. Recent data suggest that a number of critical molecules are variably expressed on the surface of human MC. In fact, depending on the environment (organ), stage of cell maturation, type of disease, and other factors, MC express variable amounts of activation-linked antigens (CD25, CD63, CD69, CD88), cell recognition molecules (CD2, CD11, CD18, CD50, CD54), or cytokine receptors. At present, however, little is known about the mechanisms and regulation of expression of such antigens. The present article gives an overview of MC phenotypes in health and disease, and attempts to provide explanations for the phenotypic variability of MC.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 74 条
[1]   Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes [J].
Agis, H ;
Fureder, W ;
Bankl, HC ;
Kundi, M ;
Sperr, WR ;
Willheim, M ;
BoltzNitulescu, G ;
Butterfield, JH ;
Kishi, K ;
Lechner, K ;
Valent, P .
IMMUNOLOGY, 1996, 87 (04) :535-543
[2]  
AGIS H, 1993, J IMMUNOL, V151, P4221
[3]   ICAM-3 (CD50) is expressed by human mast cells: Induction of homotypic mast cell aggregation via ICAM-3 [J].
Babina, M ;
Mammeri, K ;
Henz, BM .
CELL ADHESION AND COMMUNICATION, 1999, 7 (03) :195-209
[4]  
Baghestanian M, 1996, EXP HEMATOL, V24, P1377
[5]   INCREASE AND REDISTRIBUTION OF CARDIAC MAST-CELLS IN AURICULAR THROMBOSIS - POSSIBLE ROLE OF KIT-LIGAND [J].
BANKL, HC ;
RADASZKIEWICZ, T ;
KLAPPACHER, GW ;
GLOGAR, D ;
SPERR, WR ;
GROSSSCHMIDT, K ;
BANKL, H ;
LECHNER, K ;
VALENT, P .
CIRCULATION, 1995, 91 (02) :275-283
[6]  
Beil WJ, 1998, EXP HEMATOL, V26, P158
[7]  
Bühring HJ, 1999, BLOOD, V94, P2343
[8]   INTERLEUKIN-3-DEPENDENT AND INTERLEUKIN-3-INDEPENDENT MAST-CELLS STIMULATED WITH IGE AND ANTIGEN EXPRESS MULTIPLE CYTOKINES [J].
BURD, PR ;
ROGERS, HW ;
GORDON, JR ;
MARTIN, CA ;
JAYARAMAN, S ;
WILSON, SD ;
DVORAK, AM ;
GALLI, SJ ;
DORF, ME .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (01) :245-257
[9]  
Ceponis A, 1998, J RHEUMATOL, V25, P2304
[10]   MAST-CELL LEUKEMIA - EVIDENCE FOR BONE-MARROW ORIGIN OF THE PATHOLOGICAL CLONE [J].
DALTON, R ;
CHAN, L ;
BATTEN, E ;
ERIDANI, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (02) :397-406